| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.004 |